China Universal CNI BIOMEDICINE ETF (159839) last traded at RMB 0.41, with margin net buying of RMB 4.4087 million on the previous trading day

NewTimeSpace (newtimespace.com) News, As of 13:50 on August 20, 2026, the CNI Biomedicine Index (399441) surged 5.80%, and the China Universal CNI BIOMEDICINE ETF (159839) last traded at RMB 0.41.

In terms of liquidity, the China Universal CNI BIOMEDICINE ETF (159839) posted an intraday turnover rate of 11.63%, with turnover of RMB 116 million, and market trading was active. Over a longer horizon, as of August 19, the ETF's average daily turnover over the past month stood at RMB 66.4525 million.

Data shows that leveraged funds continue to build positions. The China Universal CNI BIOMEDICINE ETF (159839) posted margin net buying of RMB 4.4087 million on the previous trading day, with the latest margin balance reaching RMB 44.2417 million. (Source: Wind)

As of August 19, the China Universal CNI BIOMEDICINE ETF (159839) delivered a NAV increase of 22.22% over the past 2 years. In terms of return capability, as of August 19, 2026, since its inception the ETF's highest single-month return was 27.69%, its longest streak of consecutive monthly gains was 5 months, with the longest winning-streak gain of 31.17%, and the average return in rising months was 5.71%. As of August 19, 2026, the ETF's annualized return in excess of its benchmark over the past 3 months was 8.32%, ranking 1/3 among comparable funds.

In terms of drawdown, as of August 19, 2026, the ETF's drawdown relative to its benchmark over the past six months was 0.19%. The number of days to recover from the drawdown was 37 days, the fastest post-drawdown recovery among comparable funds.

In terms of fees, the China Universal CNI BIOMEDICINE ETF (159839) has a management fee rate of 0.50% and a custody fee rate of 0.10%, the lowest among comparable funds.

In terms of tracking precision, as of August 19, 2026, the ETF's tracking error over the past 5 years was 0.031%, the highest tracking precision among comparable funds.

The China Universal CNI BIOMEDICINE ETF (159839) closely tracks the CNI Biomedicine Index. The CNI Biomedicine Index uses the listed companies in the biomedical industry across the Shanghai, Shenzhen, and Beijing exchanges as its sample universe, and selects the top 30 securities as index constituents based on a composite ranking of market capitalization and liquidity, reflecting the overall performance of the biomedical industry and providing the market with an indexed investment vehicle for the sub-sector.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.